- Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
-
Xu G, Wang YM, Ying MM, Chen SD, Li ZR, Ma HL, Zheng MH, Wu J, Ding C
- KMID: 2514774
- Clin Mol Hepatol.
- 2021 Apr;27(2):329-345.
- doi: 10.3350/cmh.2020.0261
Background/Aims: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of... -
- CITED
-
- Close
- SHARE
-
- Close
